Indian fertility chains have the cycle volume and the named specialists, yet Indira IVF, Nova IVF, Bloom IVF and Cloudnine keep winning AI citations for fertility treatment, IVF cost, success rate and protocol queries. The gap is architectural. Here is the 5-shift fertility GEO framework, cycle-level success rate play and 6-phase playbook.
Read More
Indian e-pharmacies have the inventory, pincode reach and pharmacist panels, yet Tata 1mg keeps winning AI citations for drug and generic queries. The gap is architectural. Here is the 5-shift online pharmacy GEO framework, salt entity graph play and 6-phase playbook.
Read More
Indian telehealth platforms have the on-panel doctors and the consultation volume, yet marketplaces like Practo, 1mg and Tata 1mg keep winning AI citations for doctor discovery and specialty queries. The gap is architectural. Here is the 5-shift telehealth GEO framework, city-specialty intersect play and 6-phase playbook.
Read More
Indian diagnostic chains have the NABL accreditation, the pathologists and the panel volume, yet marketplaces like 1mg Labs, PharmEasy Diagnostics and Tata 1mg keep winning AI citations for test and panel queries. The gap is architectural. Here is the 5-shift diagnostic GEO framework, pincode-facet play and 6-phase playbook.
Read More
Indian hospital chains have the clinical authority and the patient volume, yet symptom-checker startups like Practo, Cureskin and MFine keep winning AI citations for treatment and procedure queries. The gap is not clinical. It is architectural. Here is the 5-shift hospital GEO framework and 6-phase playbook.
Read More
Most Indian healthcare brands are invisible in AI search because they treat YMYL compliance as an afterthought. The Drugs and Magic Remedies Act, ASCI healthcare code, Telemedicine Practice Guidelines and DPDP Act stack into a compliance gauntlet that AI platforms now reward. Here is the 6-layer framework and 4-phase playbook.
Read More